Comparison of Human Ocular Distribution of Bimatoprost and Latanoprost-Reference-Cited by-同舟云学术

Comparison of Human Ocular Distribution of Bimatoprost and Latanoprost

Published:2012-04 Issue:2 Volume:28 Page:134-145
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Ichhpujani Parul¹,Katz L. Jay¹,Hollo Gabor²,Shields Carol L.³,Shields Jerry A.³,Marr Brian³,Eagle Ralph⁴,Alvim Heryberto¹,Wizov Sheryl S.¹,Acheampong Andrew⁵,Chen June⁶,Wheeler Larry A.⁶

Affiliation:

1. Anne V. Goldberg Glaucoma Service, Willis Eye Institute, Philadelphia, Pennsylvania.

2. Department of Ophthalmology, Semmelweis University, Budapest, Hungary.

3. Oncology Service, Willis Eye Institute, Philadelphia, Pennsylvania.

4. Department of Pathology, Willis Eye Institute, Philadelphia, Pennsylvania.

5. Department of Safety Evaluation, Allergan, Inc., Irvine, California.

6. Department of Biological Sciences, Allergan, Inc., Irvine, California.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2011.0097

Reference29 articles.

1. Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%

2. Mechanism of Action of Bimatoprost (Lumigan™)

3. The Effects on Aqueous Dynamics of PhXA41, a New Prostaglandin F2α Analogue, After Topical Application in Normal and Ocular Hypertensive Human Eyes

4. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma

5. Mechanism of Action of Bimatoprost, Latanoprost, and Travoprost in Healthy Subjects

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular drug-metabolizing enzymes: focus on esterases;Drug Metabolism Reviews;2024-06-19

2. From Eye Care to Hair Growth: Bimatoprost;Pharmaceuticals;2024-04-27

3. The Multifarious Effects of Various Glaucoma Pharmacotherapy on Corneal Endothelium: A Narrative Review;Ophthalmology and Therapy;2023-03-17

4. A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension;Asian Journal of Pharmaceutical Sciences;2022-11

5. Long-term Effects of Latanoprost with Different Excipient Compositions on Intraocular Pressure, Hyperemia and Discomfort;Journal of the Korean Ophthalmological Society;2022-09-15